Wistar researchers successfully evaluated a simple intervention that could unlock higher anti-tumour potential in T-cell therapies, a strategy known as "cell-based therapy," which uses specifically tailored T cells to combat cancer.
Chennai (Tamil Nadu) [India], December 28: Kauvery Hospital Main Alwarpet, a unit of Kauvery Group of Hospitals, successfully removed a complex spinal cord tumour. The surgery which lasted for 28 hours was performed by a multidisciplinary team of surgeons marking a significant milestone in t
Pancreatic cancer is difficult to treat because it spreads quickly and has a distinct biochemical makeup. However, researchers achieved a significant advance by discovering the genetic changes that occur during tumour migration -- and they also discovered a medication that may block the proc
Cancerous tumours consist of a mixture of cells, the most important of which are cancer stem cells. These cells are capable of establishing new cancerous tumours by evading the immune response.
New research led by NYU Langone Health and its Perlmutter Cancer Centre suggested that rather than analyzing the tumours themselves, genetic data from seemingly healthy tissue close to lung tumours may be a better indicator of whether cancer will recur after treatment.
According to new research headed by NYU Langone Health and its Perlmutter Cancer Centre, genetic information taken from seemingly healthy tissue near lung tumours may be a better predictor of whether cancer will return following therapy than analysis of the tumours themselves.
Professor Nicholas Tonks' laboratory identified an antibody that can suppress an enzyme that may aid in the spread of some breast tumours. With more research, the antibody may be able to give a feasible therapeutic treatment for the same breast cancers.
A Duke Health team has discovered a way to launch a molecular warhead that can eradicate the bacterium that causes Lyme disease, using a method that has demonstrated promise in targeting cancer tumours.
An antibody developed in the lab of Cold Spring Harbour Laboratory Professor Nicholas Tonks can inhibit an enzyme that may aid in the spread of some breast tumours. With additional research, the antibody could provide a viable therapeutic treatment for the same breast tumours.
In theory, a team from the University of Massachusetts Amherst proved that a protein antigen from a childhood vaccine may be administered into the cells of a malignant tumour to reorient the body's immune system against the cancer, effectively stopping it and preventing its recurrence.
A group led by scientists at The University of Texas at Austin has discovered a brand-new, bio-inspired medication that restores the capability of immune cells to combat cancer. The medication increases the effectiveness of immunotherapy and inhibits tumour growth in mice models of melanoma,